Rebamipide enema therapy for left-sided ischemic colitis patients accompanied by ulcers: Open label study

Table 2 Clinical features of the ischemic colitis patients: Comparison between the rebamipide and conventional therapy groups

	Conventional group (n = 9)	Rebamipide group (n = 6)	Statistical significance
Age (mean, range, yr)	68 ± 19 (35-87)	69 ± 16 (41-85)	NS
Percentage of females (%)	77.8	66.7	NS
Lesion location: left colon (%)	88.9	100	NS
Performance status 0-1 (%)	77.8	100	NS
WBC count (× 103/&mgr;L)	12.3 ± 4.7	13.5 ± 5.3	NS
CRP (mg/dL)	2.6 ± 4.1	1.7 ± 1.8	NS
K (mEq/L)	3.8 ± 0.4	4.2 ± 0.5	NS
Total cholesterol (mg/dL)	179.3 ± 30.6	191.2 ± 63.0	NS
TG (mg/dL)	93.3 ± 41.0	131.2 ± 74.2	NS
LDH (IU/L)	190.0 ± 42.8	202.8 ± 18.2	NS
CPK (IU/L)	80.7 ± 38.9	118.0 ± 76.6	NS

Values are the mean ± SD. The percentage of females and the lesion location were evaluated by the Fisher’s exact test. Other data were evaluated by Student’s t-test after skewing the values by log transformation. WBC: White blood cell; CRP: C-reactive protein; K: Potassium; TG: Triglyceride; LDH: Lactate dehydrogenase; CPK: Creatinine phosphokinase.